D.E. Shaw & Co’s Cano Health, Inc. CANO Stock Holding History

D.E. Shaw & Co’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-147,993	Closed	-$869K	–	4915
2023 Q4	$869K	Buy	147,993 +37,247	+34%	+$441K	﹤0.01%	3232
2023 Q3	$2.81M	Buy	+110,746	New	+$9.11M	﹤0.01%	2303
2023 Q1	–	Sell	-928	Closed	-$127K	–	5046
2022 Q4	$127K	Sell	928 -863	-48%	-$292K	﹤0.01%	4342
2022 Q3	$1.55M	Sell	1,791 -12,931	-88%	-$8.11M	﹤0.01%	3228
2022 Q2	$6.45M	Sell	14,722 -5,175	-26%	-$2.7M	0.01%	1819
2022 Q1	$12.6M	Buy	+19,897	New	+$12.5M	0.01%	1390

Other funds holding CANO

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GFPC

Global Financial Private Client Sarasota, Florida $369M AUM 34.4% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

D.E. Shaw & Co's CANO Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 147,993 shares — an estimated $869K sold.

D.E. Shaw & Co first reported a position in CANO in Q1 2022 and held it in 6 quarters. The position peaked at $12.6M in Q1 2022. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

D.E. Shaw & Co reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
D.E. Shaw & Co sold 147,993 Cano Health, Inc. shares in Q1 2024, an estimated $869K.
D.E. Shaw & Co first reported a position in Cano Health, Inc. in Q1 2022 and held it in 6 quarters.
D.E. Shaw & Co's Cano Health, Inc. position peaked at $12.6M in Q1 2022.
6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.